Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09CIX
|
|||
Former ID |
DNC013790
|
|||
Drug Name |
8-Phenyloctylcarbamic Acid Biphenyl-3-yl Ester
|
|||
Synonyms |
CHEMBL486701; 8-Phenyloctylcarbamic Acid Biphenyl-3-yl Ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C27H31NO2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCCCCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C27H31NO2/c29-27(30-26-20-13-19-25(22-26)24-17-10-6-11-18-24)28-21-12-4-2-1-3-7-14-23-15-8-5-9-16-23/h5-6,8-11,13,15-20,22H,1-4,7,12,14,21H2,(H,28,29)
|
|||
InChIKey |
IKKKZTIUGOILBU-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.